Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Phosphodiesterase 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | calcium:calmodulin dependent 3'5' cyclic | Phosphodiesterase 1 | 530 aa | 478 aa | 48.1 % |
Echinococcus multilocularis | calcium:calmodulin dependent 3',5' cyclic | Phosphodiesterase 1 | 530 aa | 488 aa | 45.9 % |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Drug uptake (functional) | = 0.02 nmol/mg | Intracellular level of putrescine in L1210 cells in the presence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 0.02 nmol/mg | Intracellular level of putrescine in L1210 cells in the presence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 0.41 nmol/mg | Intracellular level of putrescine in L1210 cells in the absence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 0.41 nmol/mg | Intracellular level of putrescine in L1210 cells in the absence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 0.6 nmol/mg | Intracellular level of spermidine in L1210 cells in the presence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 0.6 nmol/mg | Intracellular level of spermidine in L1210 cells in the presence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 1.8 nmol/mg | Intracellular level of conjugate in L1210 cells in the absence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 1.8 nmol/mg | Intracellular level of conjugate in L1210 cells in the absence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 2.6 nmol/mg | Intracellular level of conjugate in L1210 cells in the presence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 2.6 nmol/mg | Intracellular level of conjugate in L1210 cells in the presence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (ADMET) | = 3.2 nmol/mg | Cellular uptake in CHO-MG cells at 50 uM | ChEMBL. | 16392808 |
Drug uptake (ADMET) | = 3.3 nmol/mg | Cellular uptake in CHO cells at 50 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 7.6 nmol/mg | Intracellular level of spermine in L1210 cells in the presence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 7.6 nmol/mg | Intracellular level of spermine in L1210 cells in the presence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 9.5 nmol/mg | Intracellular level of spermine in L1210 cells in the absence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 9.5 nmol/mg | Intracellular level of spermine in L1210 cells in the absence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 16 nmol/mg | Intracellular level of spermidine in L1210 cells in the absence of DFMO at 10 uM | ChEMBL. | 16392808 |
Drug uptake (functional) | = 16 nmol/mg | Intracellular level of spermidine in L1210 cells in the absence of DFMO at 10 uM | ChEMBL. | 16392808 |
IC50 (functional) | = 2.3 uM | Inhibition of cell growth in L1210 cells in the presence of DFMO | ChEMBL. | 16392808 |
IC50 (functional) | = 2.3 uM | Inhibition of cell growth in L1210 cells in the presence of DFMO | ChEMBL. | 16392808 |
IC50 (binding) | = 8 uM | Inhibition of bovine calmodulin-activated cAMP dependent phosphodiesterase | ChEMBL. | 16392808 |
IC50 (binding) | = 8 uM | Inhibition of bovine calmodulin-activated cAMP dependent phosphodiesterase | ChEMBL. | 16392808 |
Selectivity ratio (functional) | = 1 | Selectivity for uptake CHO cell line over CHO-MG cell line at 50 uM | ChEMBL. | 16392808 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 16392808 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.